Prostamax
Also known as: Lys-Glu-Asp-Pro, Khavinson prostate peptide, Prostatic bioregulator
Prostamax is a tetrapeptide bioregulator (Lys-Glu-Asp-Pro) developed by Professor Vladimir Khavinson, tissue-specific for the prostate gland. It supports prostate epithelial cell function, promotes normalization of prostate tissue, and is studied for its potential in benign prostatic hyperplasia (BPH), prostatitis, and prostate anti-aging. It is one of the more widely used Khavinson bioregulators among men over 40.
Half-Life
Short (minutes); sustained gene-regulatory effects
Route
SubQ, Oral
Category
Anti-Aging & Longevity
Studies
3 references
Key Benefits
- Supports normalization of prostate tissue architecture
- May reduce prostate enlargement associated with BPH
- Anti-inflammatory effects on prostatic tissue
- Reduces prostate cell apoptosis from oxidative stress
- Potential support in chronic prostatitis
- Anti-aging effects on prostate glandular tissue
- Complementary to conventional BPH therapies
Mechanism of Action
Prostamax acts as a gene expression modulator in prostate epithelial and stromal cells. The tetrapeptide Lys-Glu-Asp-Pro interacts with chromatin in prostate tissue, normalizing protein synthesis, reducing abnormal cellular proliferation associated with BPH, and supporting healthy glandular architecture. It reduces inflammatory cytokine expression in prostate tissue and may inhibit excessive androgen receptor signaling contributing to prostatic enlargement.
Dosing Protocols
Standard Khavinson Protocol
- Dose
- 10 mg per day
- Frequency
- Daily for 10–30 days
- Timing
- Subcutaneous injection or oral (enteric-coated)
- Cycle
- 10–30 day course, repeated 2–4x per year
Often combined with Testagen in men's health protocols. Research use only.
Calculate your draw volume
Enter your vial size and BAC water to get exact injection volumes
Side Effects
- Generally well tolerated in available research
- Mild injection site reactions
- No significant adverse urological events reported at standard doses
Contraindications
Not FDA approved. Not a substitute for alpha-blockers, 5-alpha reductase inhibitors, or other BPH treatments. Medical oversight required for prostate conditions or elevated PSA.
Storage
Store at 2–8°C. Protect from moisture and light.
Clinical Research
- 1.Peptides (Epigenetic Regulators) in the Structure of Rodents with a Long and Short Lifespan
Khavinson VK, Kormilets DY, Mar'yanovich AT · Bulletin of experimental biology and medicine · 2017PubMed Verified
- 2.Microcalorimetric study of human blood lymphocytes culture at presence of copper, cadmium and prostamax
Kiladze M, Gorgoshidze M, Monaselidze J, Jokhadze T, Lezhava T · Georgian medical news · 2009PubMed Verified
- 3.Effects of short peptides on lymphocyte chromatin in senile subjects
Khavinson VKh, Lezhava TA, Malinin VV · Bulletin of experimental biology and medicine · 2004PubMed Verified
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice. Many compounds listed are research chemicals not approved for human use. Always consult a qualified healthcare professional before starting any protocol.
Was this page helpful?
Launching soon
Build and track your protocol in Staqk
Log doses, track timing, monitor biomarkers, and manage every compound in your stack — all in one place.